Krystal Biotech Inc Research & Development Oncology Program Announcement Call Transcript
Thank you for standing by, and welcome to the Krystal Biotech R&D Oncology Program Announcement Investor Conference Call. As a reminder, today's conference is being recorded.
I would now like to hand the conference over to your host, Meg Dodge, Head of Investor Relations and Corporate Communications. Please begin.
Hello, and thank you for joining us today for the announcement of Krystal's Oncology Program. Joining us today from Krystal is Chairman and Chief Executive Officer, Krish Krishnan; Co-Founder and President of Research and Development, Suma Krishnan; Dr. Samuel Broder, Former Director of the National Cancer Institute; Dr. David Chien, Senior Vice President of Clinical Development; and Dr. Trevor Parry, Vice President of Research and Scientific Affairs at Krystal.
Also with us on the call is Dr. Jason Luke, Associate Professor of Medicine in the Division of Hematology/Oncology and Director of the Cancer Immunotherapeutic Center within the University of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |